Skip to main content
SpringerLink
Log in
Book cover

Klinische Neurologie pp 687–721Cite as

Hirntumoren

  • Chapter

  • 13k Accesses

Zusammenfassung

Primäre intrakranielle Tumoren gehen vom Gehirn, den Hirnhäuten (Meningen) und seinen Anhangsgebilden (Hypophyse, Epiphyse) aus. Sie lösen durch Kompression, Infiltration, Ischämie oder Irritation neurologische Symptome aus. Sekundäre Hirntumoren sind Metastasen eines extrazerebralen Primärtumors, dessen Tochterzellen in der Regel hämatogen ins Gehirn gelangen.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   189.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

Zitierte Literatur

  • Abrey LE, Batchelor TT, Ferreri AJM et al. (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23: 5034–5043

    Article  PubMed  Google Scholar 

  • Andrews DW, Scott CB, Sperduto PW et al. (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: Phase III results of the RTOG 9508 randomised trial. Lancet 363: 1665–1672

    Article  PubMed  Google Scholar 

  • Aoyama H, Shirato H, Tago M et al. (2006) Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgrey alone for treatment of brain metastases: A randomised controlled trial. J Am Med Assoc 295: 2483–2491

    Article  CAS  Google Scholar 

  • Bent MJ van den, Afra D, Witte O de et al. (2005) Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366: 985–990.

    Article  PubMed  Google Scholar 

  • Bent MJ van den, Carpentier AF, Brandes AA et al. (2006) Adjuvant Procarbazine, Lomustine, and Vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: A randomized European Organisation for Research and Treatment of Cancer Phase III Trial. J Clin Oncol 24 2715–2722

    Article  PubMed  Google Scholar 

  • Boedeker CC, Ridder GJ, Schipper J (2005) Paragangliomas of the head and neck: Diagnosis and treatment. Fam Cancer 4(1): 55–59.

    Article  PubMed  CAS  Google Scholar 

  • Bokstein F, Lossos A, Siegal T (1998) Leptomeningeal metastases from solid tumors: A comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82: 1756–1763

    Article  PubMed  CAS  Google Scholar 

  • Bruce JN, Ogden AT (2004) Surgical strategies for treating patients with pineal region tumors. J Neurooncol 69: 221–236

    Article  PubMed  Google Scholar 

  • Caceres A (2005) Intracavitary therapeutic options in the management of cystic craniopharyngioma. Childs Nerv Syst 21: 705–718

    Article  PubMed  Google Scholar 

  • Cairncross G, Berkey B, Shaw E et al. (2006) Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402. J Clin Oncol 24: 2707–2714

    Article  PubMed  CAS  Google Scholar 

  • Combs SE, Thilmann C, Edler L et al. (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: Long-term results in 172 patients treated in a single institution. J Clin Oncol 23: 8863–8869

    Article  PubMed  Google Scholar 

  • Cuccia V, Rodriguez F, Palma F et al. (2006) Pinealoblastomas in children. Childs Nerv Syst 22: 577–585

    Article  PubMed  Google Scholar 

  • DeAngelis LM (2001) Brain tumors. N Engl J Med 344: 114–123

    Article  PubMed  CAS  Google Scholar 

  • DeAngelis LM, Gutin PH, Leibel SA et al. (2002) Neoplastic cysts and cyst-like tumors. In: DeAngelis LM, Gutin PH, Leibel SA et al. (eds) Intracranial tumors. London: Martin Dunitz, pp 356–366

    Google Scholar 

  • Debus J, Wuendrich M, Pirzkall A et al. (2001) High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: Longterm results. J Clin Oncol 19: 3547–3553

    PubMed  CAS  Google Scholar 

  • De Munnynck K, Van Gool S, Van Calenbergh F et al. (2002) Desmoplastic infantile ganglioglioma: A potentially malignant tumor? Am J Surg Pathol 26: 1515–1522

    Article  PubMed  Google Scholar 

  • Ekenel M, Iwamoto FM, Ben-Porat LS et al. (2008) Primary central nervous system lymphoma: The role of consolidation treatment after a complete response to high-dose methotrexate-based chemotherapy. Cancer 113(5): 1025–1031

    Article  PubMed  CAS  Google Scholar 

  • Friedman H, Prados MD, Wen PY et al. (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27 (28): 4733–4740

    Article  PubMed  CAS  Google Scholar 

  • Fischer L, Martus P, Weller M et al. (2008) Meningeal dissemination in primary CNS lymphoma: Prospective evaluation of 282 patients. Neurology 71: 1102–1108

    Article  PubMed  CAS  Google Scholar 

  • Fuentes R, Bonfill X, Exposito J (2006) Surgery versus radiosurgery for patients with a solitary brain metastasis from non-small cell lung cancer. Cochrane Database Syst Rev 1, CD004840

    Google Scholar 

  • Glantz MJ, Cole BF, Recht L et al. (1998) High-dose intravenous methotrexate for patients with nonleukemic cancer: Is intrathecal chemotherapy necessary? J Clin Oncol 16: 1561–1567

    PubMed  CAS  Google Scholar 

  • Gnekow AK, Kortmann RD, Pietsch T et al. (2004) Low grade chiasmatic-hypothalamic glioma-carboplatin and vincristine chemotherapy effectively defers radiotherapy within a comprehensive treatment strategy – report from the multicenter treatment study for children and adolescents with a low grade glioma – HIT-LGG 1996 – of the Society of Pediatric Oncology and Hematology (GPOH). Klin Pädiatr 216: 331–342

    Article  PubMed  CAS  Google Scholar 

  • Hargrave D, Bartels U, Bouffet E (2006) Diffuse brainstem glioma in children: Critical review of clinical trials. Lancet Oncol 7: 241–248

    Article  PubMed  Google Scholar 

  • Hartmann C, Meyer J et al. (2009) Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: A study of 1,010 diffuse gliomas. Acta Neuropathol 118 : 469–474

    Article  PubMed  Google Scholar 

  • Hegi ME, Diserens AC et al. (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352(10): 997–1003

    Article  PubMed  CAS  Google Scholar 

  • Herrlinger U, Förschler H, Küker W et al. (2004). Leptomeningeal metastasis: Survival and prognostic factors in 155 patients. J Neurol Sci 223: 167–178

    Article  PubMed  Google Scholar 

  • Hilden JM, Meerbaum S, Burger P (2004) Central nervous system atypical teratoid/rhabdoid tumor: Results of therapy in children enrolled in a registry. J Clin Oncol 22: 2877–2884

    Article  PubMed  Google Scholar 

  • Illerhaus G, Marks R, Ihorst G et al. (2006) High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma. J Clin Oncol 24: 3865–3870

    Article  PubMed  CAS  Google Scholar 

  • Jahnke K, Thiel E, Martus P et al. (2006) Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Hematol 85: 45–50

    Article  PubMed  Google Scholar 

  • Jenkins RB, Blair H, Ballman KV et al. (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66: 9852–9861

    Article  PubMed  CAS  Google Scholar 

  • Kaloshi G, Benouaich-Amiel A et al. (2007) Temozolomide for low-grade gliomas: Predictive impact of 1 p/19q loss on response and outcome. Neurology 68(21): 1831–1836

    Article  PubMed  CAS  Google Scholar 

  • Kleihues P, Cavanee (2000) World Health Organization classification of tumours. Pathology and genetics.Tumours of the nervous system. IARC Press, Lyon

    Google Scholar 

  • Kreisl TN, Kim L et al. (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27(5): 740–745

    Article  PubMed  CAS  Google Scholar 

  • Kurian KM, Summers DM, Statham PF et al. (2005) Third ventricular chordoid glioma: Clinicopathological study of two cases with evidence for a poor clinical outcome despite low grade histological features. Neuropathol Appl Neurobiol 31: 354–361

    Article  PubMed  CAS  Google Scholar 

  • Leenstra JL, Rodriguez FJ, Frechette CM et al. (2007) Central neurocytoma: Management recommendations based on a 35-year experience. Int J Radiat Oncol Biol Phys 67(4): 1145–1154

    Article  PubMed  Google Scholar 

  • Lönnroth K, Terho M, Kähärä V et al. (2007) Desmoplastic infantile ganglioglioma: Novel aspects in clinical presentation and genetics. Surg Neurol 68(3): 304–308

    Article  Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD et al. (2007a) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. The International Agency for Research on Cancer (IARC), 4th edn. IARC Press, Lyon

    Google Scholar 

  • Luyken C, Blümcke I, Fimmers R et al. (2004) Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow-up of 8 years. Cancer 101(1): 146–155

    Article  PubMed  Google Scholar 

  • Mavrakis AN, Halpern EF, Barker FG 2nd et al. (2005) Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer. Neurology 65: 908–911

    Article  PubMed  CAS  Google Scholar 

  • McGirt MJ, Chaichana KL et al. (2008) Independent association of extent of resection with survival in patients with malignant brain astrocytoma. J Neurosurg 110(1): 156–162

    Google Scholar 

  • Packer RJ, Gajjar A, Vezina G et al. (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol 24: 4202–4208

    Article  PubMed  CAS  Google Scholar 

  • Patchell RA, Tibbs PA, Walsh JW et al. (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500

    Article  PubMed  CAS  Google Scholar 

  • Patchell RA, Tibbs PA, Regine WF et al. (1998) Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. Jama 280: 1485–1489

    Article  PubMed  CAS  Google Scholar 

  • Reifenberger G, Louis DN (2003) Oligodendroglioma: Toward molecular definitions in diagnostic neuro-oncology. J Neuropathol Exp Neurol 62: 111–126

    PubMed  CAS  Google Scholar 

  • Rosenblum MK, Matsutani M, Van Meir EG (2000) CNS germ cell tumors. In: Kleihues P, Cavanee W (eds) Pathology and genetics of tumors of the Nervous System. IARC Press, Lyon, pp 208–214

    Google Scholar 

  • Roa W, Brasher PM, Bauman G et al. (2004) Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: A prospective randomized clinical trial. J Clin Oncol 22: 1583–1588

    Article  PubMed  CAS  Google Scholar 

  • Sawamura Y, Tribolet ND de (2006) Tumors of the pineal region. In: Tonn J-C, Westphal M, Rutka JT et al. (eds) Oncology of CNS tumors. Springer, Berlin Heidelberg New York Tokyo, pp 208–215

    Google Scholar 

  • Schlegel U, Korfel A, Thiel E et al. (2009) Primäre ZNS Lymphome. Onkologe 15: 211–221

    Article  Google Scholar 

  • Shah GD, Yahalom J, Correa DD et al. (2007) Combined immunochemotherapy with reduced whole-brain radiotherapy for newly diagnosed primary CNS lymphoma. J Clin Oncol 25: 4730–4735

    Article  PubMed  CAS  Google Scholar 

  • Silvani A, Eoli M, Salmeggi A et al. (2005) Combined chemotherapy and radiotherapy for intracranial germinomas in adult patients: A single-institution study. J Neurooncol 71: 271–276

    Article  PubMed  CAS  Google Scholar 

  • Smith JS, Chang EF et al. (2008) Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26(8): 1338–1345

    Article  PubMed  Google Scholar 

  • Stummer W, Pichlmeier U, Meinel T et al. (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: A randomised controlled multicentre phase III trial. Lancet Oncol 7: 392–401

    Article  PubMed  CAS  Google Scholar 

  • Stupp R, Mason WP, Van den Bent MJ et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for patients with newly diagnosed glioblastoma. N Engl J Med 352: 987–996

    Article  PubMed  CAS  Google Scholar 

  • Stupp R, Hegi ME et al. (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 10(5): 459–466

    Article  PubMed  CAS  Google Scholar 

  • Tekautz TM, Fuller CE, Blaney S et al. (2005) Atypical teratoid/rhabdoid tumors (ATRT): Improved survival in children 3 years of age and older with radiation therapy and high-dose alkylator-based chemotherapy. J Clin Oncol 23: 1491–1499

    Article  PubMed  CAS  Google Scholar 

  • Vecht CJ, Breemen M van (2006) Optimizing therapy of seizures in patients with brain tumors. Neurology 67 (Suppl 4): 10–13

    Google Scholar 

  • Vredenburgh JJ, Desjardins A et al. (2007) Bevacizumab plus irinotecan in recurrent glioblastoma multiforme. J Clin Oncol 25(30): 4722–4729

    Article  PubMed  CAS  Google Scholar 

  • Weller M (Hrsg) (2008a) Für die Neuro-Onkologische Arbeitsgemeinschaft (NOA) in der Deutschen Krebsgesellschaft. Leitlinie Diagnostik und Therapie der zerebralen Metastasen. Zuckschwerdt, München

    Google Scholar 

  • Weller M (Hrsg) (2008b) Für die Neuro-Onkologische Arbeitsgemeinschaft (NOA) in der Deutschen Krebsgesellschaft. Leitlinie Diagnostik und Therapie der Spinalen Metastasen und der Meningeosis neoplastica. Zuckschwerdt, München

    Google Scholar 

  • Westphal M, Tonn JC (2006) Meningiomas and meningeal tumors. In: Tonn JC, Westphal M, Rutka JT et al. (Hrsg) Neuro-Oncology of CNS Tumors. Springer, Berlin Heidelberg New York Tokyo, pp 81–101

    Chapter  Google Scholar 

  • Wick W, Steinbach JP, Küker WM et al. (2004) One week on/one week off: A novel active regimen of temozolomide for recurrent glioblastoma. Neurology 62: 2113–2115

    PubMed  CAS  Google Scholar 

  • Wick A, Pascher et al. (2009a) Rechallenge with temozolomide in patients with recurrent gliomas. J Neurol 256(5): 734–741

    Article  CAS  Google Scholar 

  • Wick W, Hartmann C, Engels C et al. (2009b) NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide. J Clin Oncol 27(35): 5874–5880

    Article  CAS  Google Scholar 

  • Wrede B, Liu P, Ater J et al. (2005) Second surgery and the prognosis of choroid plexus carcinoma – results of a meta-analysis of individual cases. Anticancer Res 25: 4429–4433

    PubMed  Google Scholar 

  • Yan H, Parsons DW et al. (2009) IDH1 and IDH2 mutations in gliomas. N Engl J Med 360(8): 765–773

    Article  PubMed  CAS  Google Scholar 

  • Yen CP, Sheehan J, Patterson G et al. (2006) Gamma knife surgery for metastatic brain stem tumors. J Neurosurg 105: 213–219

    Article  PubMed  Google Scholar 

  • Yung WK, Prados MD, Yaga-Tur R et al. (1999) Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. J Clin Oncol 17: 2762–2771

    PubMed  CAS  Google Scholar 

Weiterführende Literatur

  • Diener HC, Putzki N et al. für die DGN (Hrsg) (2008) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart

    Google Scholar 

  • Louis DN, Ohgaki H, Wiestler OD et al. (2007a) World Health Organization classification of tumours. Pathology and genetics of tumours of the nervous system. The International Agency for Research on Cancer (IARC), 4th edn. IARC Press, Lyon

    Google Scholar 

  • Schlegel U, Weller M, Westphal M (Hrsg) (2009) Neuroonkologische Therapie. Kohlhammer, Stuttgart

    Google Scholar 

  • Tonn J-C, Westphal M, Rutka JT et al. (eds) Oncology of CNS tumors. Springer, Berlin Heidelberg New York Tokyo

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neurologische Universitätsklinik, Knappschafts-Krankenhaus, In der Schornau 23–25, 44892, Bochum

    Prof. Dr. U. Schlegel

Authors
  1. Prof. Dr. U. Schlegel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik für Neurologie, Alfried Krupp Krankenhaus Rüttenscheid, Alfried-Krupp-Straße 21, 45117, Essen

    Peter Berlit

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schlegel, U. (2011). Hirntumoren. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-16920-5_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-16920-5_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-16919-9

  • Online ISBN: 978-3-642-16920-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation